Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In line with UK Summary of Product Characteristics (SmPC) guidance for approved agents in this class: Retatrutide should not be used during pregnancy
Unlike some compounds requiring strict cycle lengths for safety reasons, Retatrutide can be used for extended periods when properly managed
Semaglutide significantly improves symptoms in men and women with a common type of heart failure
Primary-care notes documenting symptom onset, referrals, and medication changes
Important Update: As of May 2025, compounded semaglutide is no longer available for routine compounding following the FDAs determination that the semaglutide shortage has been resolved
Other GLP-1 products Health Canada's authorizations to date concern semaglutide injections referencing brand-name Ozempic
US$ 22.08
US$ 28.85
US$ 21.08
